DNM2 and melanoma: As ALDOC interacts with cytoskeletal proteins (e.g., F‐actin, tubulin) [30] and alters the migratory capacity of tumor cells [9], we examined whether ALDOC overexpressing melanoma cells would manifest an altered ability to migrate through collagen‐coated transwells.